Literature DB >> 12690592

A protocol of electroejaculation and systematic assisted reproductive technology achieved high efficiency and efficacy for pregnancy for anejaculatory men with spinal cord injury.

Jeng-Yi Shieh1, Shee-Uan Chen, Yen-Ho Wang, Hong-Chiang Chang, Hong-Nerng Ho, Yu-Shih Yang.   

Abstract

OBJECTIVE: To help anejaculatory men with spinal cord injury (SCI) to procreate.
DESIGN: Prospective, clinical study.
SETTING: A team of physiatrists, urologists, and gynecologists at a university hospital in Taiwan. PARTICIPANTS: Ten infertile men with SCI seen at our hospital between 1995 and 2001.
INTERVENTIONS: Electroejaculation induced their seminal emission. Depending on semen parameters, the couples were treated with intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI), surgical retrieval of sperm, cryopreservation of sperm, or donor sperm. MAIN OUTCOME MEASURES: Fertilization and pregnancy.
RESULTS: Ten couples underwent assisted reproductive technology (ART). One couple achieved pregnancy after the second cycle of electroejaculation and IUI. Seven couples underwent 8 cycles of ICSI, 4 cycles with fresh electroejaculates, 2 with cryopreserved samples, and 2 with cryopreserved samples with addition of pentoxifylline. Seven (88%) clinical pregnancies were achieved, 2 of which ended with spontaneous abortion. One couple accomplished pregnancy by ICSI with cryopreserved sperm from vasal aspiration. The percentages of fertilization and pregnancy of ICSI cycles using sperm from men with SCI were comparable to men without SCI. One couple attained pregnancy by using donor sperm. The cumulative successful pregnancy rate per couple was 80% (8/10).
CONCLUSION: Electroejaculation and systematic ART are highly efficient for achieving pregnancy with the spouses of men with SCI. The neurologic deficit and electroejaculation did not affect the outcome of ICSI. Using cryopreserved sperm for ICSI may reduce risk from electroejaculation or surgery.

Entities:  

Mesh:

Year:  2003        PMID: 12690592     DOI: 10.1053/apmr.2003.50126

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

1.  Sexuality and reproductive health in adults with spinal cord injury: a clinical practice guideline for health-care professionals.

Authors: 
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

Review 2.  A step-wise approach to sperm retrieval in men with neurogenic anejaculation.

Authors:  Mikkel Fode; Dana A Ohl; Jens Sønksen
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

Review 3.  Male sexual dysfunction and infertility associated with neurological disorders.

Authors:  Mikkel Fode; Sheila Krogh-Jespersen; Nancy L Brackett; Dana A Ohl; Charles M Lynne; Jens Sønksen
Journal:  Asian J Androl       Date:  2011-12-05       Impact factor: 3.285

4.  Prevalence of parenthood in wheelchair-dependent persons with long-term spinal cord injury in the Netherlands.

Authors:  K van den Borne; I Brands; D Spijkerman; J J E Adriaansen; K Postma; H J G van den Berg-Emons
Journal:  Spinal Cord       Date:  2018-01-19       Impact factor: 2.772

Review 5.  Improving Sexual Satisfaction in Persons with Spinal Cord Injuries: Collective Wisdom.

Authors:  Marcalee Alexander; Frédérique Courtois; Stacy Elliott; Mitchell Tepper
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

6.  Outcomes with intracytoplasmic sperm injection of cryopreserved sperm from men with spinal cord injury.

Authors:  Shaliha Bechoua; Yasmine Berki-Morin; Frédéric Michel; Sophie Girod; Paul Sagot; Patricia Fauque
Journal:  Basic Clin Androl       Date:  2013-12-02

Review 7.  Infertility in men with spinal cord injury: research and treatment.

Authors:  Nancy L Brackett
Journal:  Scientifica (Cairo)       Date:  2012-11-25

Review 8.  Advances in the management of infertility in men with spinal cord injury.

Authors:  Emad Ibrahim; Nancy L Brackett; Charles M Lynne
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.